Pharma: Novartis experienced a 9% decline in stock value following three setbacks in drug trial results.

Sep 8, 2026 - 05:35

0 0

Pharma: Novartis experienced a 9% decline in stock value following three setbacks in drug trial results.

Novartis shares took a hit on Tuesday as disappointing results from the del-desiran drug trial left investors concerned. 📉 What's next for the pharma giant? #Novartis #PharmaNews

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

High mortgage rates and pricier home-equity borrowing are pushing more Americans to delay major remodeling projects, with homeowners and retailers seeing a shift from big renovations to maintenance and repairs.

High mortgage rates and pricier home-equity borrowing a...

Oct 3, 2026 0 0

Ramp staged a Broadway musical called 'Bill Pay' at the Broadhurst Theatre, featuring Billy Porter and Jessica Vosk in a public, hourlong show built around the fintech company's bill-pay pitch.

Ramp staged a Broadway musical called 'Bill Pay' at the...

Oct 3, 2026 0 0

Gen Alpha kids are earning their own money through chores, allowance, resale and side gigs, and parents can use tools like 529 plans, custodial brokerage accounts and IRAs to help them save and invest.

Gen Alpha kids are earning their own money through chor...

Oct 3, 2026 0 0

Tesla has nearly quadrupled the number of Cybercabs authorized for commercial service in Texas since its Austin rollout, but the company still faces mixed rider reviews, regulatory scrutiny, and the challenge of expanding beyond Austin.

Tesla has nearly quadrupled the number of Cybercabs aut...

Oct 3, 2026 0 0

High-tech vehicles are pushing auto repair costs higher as shops spend more on computers, software subscriptions and calibration equipment, costs mechanics say are being passed on to consumers.

High-tech vehicles are pushing auto repair costs higher...

Oct 3, 2026 0 0

McKinsey Asia chairman Gautam Kumra says top Asian owner-CEOs succeed by balancing long and short-term thinking, giving stretch opportunities, and taking risks on people, according to his CNBC interview and new book.

McKinsey Asia chairman Gautam Kumra says top Asian owne...

Oct 3, 2026 0 0